期刊文献+

Stem cell-based regenerative opportunities for the liver: State of the art and beyond 被引量:16

Stem cell-based regenerative opportunities for the liver: State of the art and beyond
下载PDF
导出
摘要 The existing mismatch between the great demand for liver transplants and the number of available donor organs highlights the urgent need for alternative therapeutic strategies in patients with acute or chronic liver failure. The rapidly growing knowledge on stem cell biology and the intrinsic repair processes of the liver has opened new avenues for using stem cells as a cell therapy platform in regenerative medicine for hepatic diseases. An impressive number of cell types have been investigated as sources of liver regeneration: adult and fetal liver hepatocytes,intrahepatic stem cell populations,annex stem cells,adult bone marrow-derived hematopoietic stem cells,endothelial progenitor cells,mesenchymal stromal cells,embryonic stem cells,and induced pluripotent stem cells. All these highly different cell types,used either as cell suspensions or,in combination with biomaterials as implantable liver tissue constructs,have generated great promise for liver regeneration. However,fundamental questions still need to be addressed and critical hurdles to be overcome before liver cell therapy emerges. In this review,we summarize the state-of-the-art in the field of stem cell-based therapies for the liver along with existing challenges and future perspectives towards a successful liver cell therapy that will ultimately deliver its demanding goals. The existing mismatch between the great demand for liver transplants and the number of available donor organs highlights the urgent need for alternative therapeutic strategies in patients with acute or chronic liver failure. The rapidly growing knowledge on stem cell biology and the intrinsic repair processes of the liver has opened new avenues for using stem cells as a cell therapy platform in regenerative medicine for hepatic diseases. An impressive number of cell types have been investigated as sources of liver regeneration: adult and fetal liver hepatocytes,intrahepatic stem cell populations,annex stem cells,adult bone marrow-derived hematopoietic stem cells,endothelial progenitor cells,mesenchymal stromal cells,embryonic stem cells,and induced pluripotent stem cells. All these highly different cell types,used either as cell suspensions or,in combination with biomaterials as implantable liver tissue constructs,have generated great promise for liver regeneration. However,fundamental questions still need to be addressed and critical hurdles to be overcome before liver cell therapy emerges. In this review,we summarize the state-of-the-art in the field of stem cell-based therapies for the liver along with existing challenges and future perspectives towards a successful liver cell therapy that will ultimately deliver its demanding goals.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第43期12334-12350,共17页 世界胃肠病学杂志(英文版)
关键词 Stem cells LIVER REGENERATION LIVER CIRRHOSIS Acut Stem cells Liver regeneration Liver cirrhosis Acut
  • 相关文献

参考文献20

  • 1Jiaojiao Xin,Wenchao Ding,Shaorui Hao,Longyan Jiang,Qian Zhou,Tianzhou Wu,Dongyan Shi,Hongcui Cao,Lanjuan Li,Jun Li.Human bone marrow mesenchymal stem cell‐derived hepatocytes express tissue inhibitor of metalloproteinases 4 and follistatin[J]. Liver Int . 2015 (10)
  • 2Isabel Pascual-Miguela?,ez,Javier Salinas-Gomez,David Fernandez-Luengas,Karen Villar-Zarra,Luz Vega Clemente,Mariano Garcia-Arranz,Damian Garcia Olmo.Systemic Treatment of Acute Liver Failure with Adipose Derived Stem Cells[J]. Journal of Investigative Surgery . 2015 (2)
  • 3Wei‐Ping Tang,Tomohiko Akahoshi,Jing‐Shu Piao,Sayoko Narahara,Masaharu Murata,Takahito Kawano,Nobuhito Hamano,Tetsuo Ikeda,Makoto Hashizume.Basic fibroblast growth factor‐treated adipose tissue‐derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor[J]. J Gastroenterol Hepatol . 2015 (6)
  • 4Sulaiman Shams,Sadia Mohsin,Ghazanfar Ali Nasir,Mohsin Khan,Shaheen N. Khan,Peter J. Quesenberry.Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice[J]. Stem Cells International . 2015
  • 5Kordes, Claus,Sawitza, Iris,G?tze, Silke,Herebian, Diran,H?ussinger, Dieter.SPQD14120800011178[J]. Journal of Clinical Investigation . 2014 (12)
  • 6Raphael P.H. Meier,Redouan Mahou,Philippe Morel,Jeremy Meyer,Elisa Montanari,Yannick D. Muller,Panayiotis Christofilopoulos,Christine Wandrey,Carmen Gonelle-Gispert,Leo H. Bühler.Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice[J]. Journal of Hepatology . 2014
  • 7Eleftheria Tsolaki,Evangelia Athanasiou,Eleni Gounari,Nikolaos Zogas,Eleni Siotou,Minas Yiangou,Achilles Anagnostopoulos,Evangelia Yannaki.Hematopoietic stem cells and liver regeneration: Differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury[J]. Blood Cells, Molecules and Diseases . 2014
  • 8Yoon Ok Jang,Young Ju Kim,Soon Koo Baik,Moon Young Kim,Young Woo Eom,Mee Yon Cho,Hong Jun Park,So Yeon Park,Bo Ra Kim,Jae Woo Kim,Hyun Soo Kim,Sang Ok Kwon,Eun Hee Choi,Yong Man Kim.Histological improvement following administration of autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study[J].Liver Int.2014(1)
  • 9Mehdi Mohamadnejad,Kamran Alimoghaddam,Mohammad Bagheri,Mandana Ashrafi,Leila Abdollahzadeh,Shahram Akhlaghpoor,Maryam Bashtar,Ardeshir Ghavamzadeh,Reza Malekzadeh.Randomized placebo‐controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis[J].Liver Int.2013(10)
  • 10Pingping Hou,Yanqin Li,Xu Zhang,Chun Liu,Jingyang Guan,Honggang Li,Ting Zhao,Junqing Ye,Weifeng Yang,Kang Liu,Jian Ge,Jun Xu,Qiang Zhang,Yang Zhao,Hongkui Deng.Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds[J]. Science . 2013 (6146)

二级参考文献2

共引文献69

同被引文献46

引证文献16

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部